img

Global End Stage Renal Disease Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global End Stage Renal Disease Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

End-stage kidney disease drugs are used widely to treat end-stage kidney disease also known as the late stage renal disease, which occurs when chronic kidney disease reaches an advanced state. In this stage, the kidneys can no longer work, as they should to meet the body's needs. It damages the nephron and the kidney cannot function to remove the waste product from the body. The disease can cause other severe problems such as kidney failure, hypertension, brain aneurysm, and chronic pain.
End Stage Renal Disease Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global End Stage Renal Disease Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from End Stage Renal Disease Induced Hyperparathyroidism and End Stage Renal Disease Induced Hyperphosphatemia are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for End Stage Renal Disease Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, End Stage Renal Disease Drug key manufacturers include Pfizer Inc, AstraZeneca, Bristol-Myers Squibb Company, Dr. Reddy's Laboratories Ltd, Endo International plc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Mylan NV and Novartis AG, etc. Pfizer Inc, AstraZeneca, Bristol-Myers Squibb Company are top 3 players and held % sales share in total in 2022.
End Stage Renal Disease Drug can be divided into Calcimimetics, Vitamin D, Sterols and Potassium Binders, etc. Calcimimetics is the mainstream product in the market, accounting for % sales share globally in 2022.
End Stage Renal Disease Drug is widely used in various fields, such as End Stage Renal Disease Induced Hyperparathyroidism, End Stage Renal Disease Induced Hyperphosphatemia and End Stage Renal Disease Induced Hyperkalaemia,, etc. End Stage Renal Disease Induced Hyperparathyroidism provides greatest supports to the End Stage Renal Disease Drug industry development. In 2022, global % sales of End Stage Renal Disease Drug went into End Stage Renal Disease Induced Hyperparathyroidism filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global End Stage Renal Disease Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer Inc
AstraZeneca
Bristol-Myers Squibb Company
Dr. Reddy's Laboratories Ltd
Endo International plc
Teva Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd
Mylan NV
Novartis AG
Lupin
Cipla Inc
Aurobindo Pharma
Fresenius SE & Co. KGaA
Sanofi
Takeda Pharmaceutical Company Limited
F. Hoffmann-La Roche Ltd
Kissei Pharmaceutical Co., Ltd
Abbott
Segment by Type
Calcimimetics
Vitamin D
Sterols
Potassium Binders
Calcium-Based Phosphate Binders
Other

Segment by Application


End Stage Renal Disease Induced Hyperparathyroidism
End Stage Renal Disease Induced Hyperphosphatemia
End Stage Renal Disease Induced Hyperkalaemia

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the End Stage Renal Disease Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of End Stage Renal Disease Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the End Stage Renal Disease Drug industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of End Stage Renal Disease Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, End Stage Renal Disease Drug introduction, etc. End Stage Renal Disease Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of End Stage Renal Disease Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 End Stage Renal Disease Drug Market Overview
1.1 End Stage Renal Disease Drug Product Overview
1.2 End Stage Renal Disease Drug Market Segment by Type
1.2.1 Calcimimetics
1.2.2 Vitamin D
1.2.3 Sterols
1.2.4 Potassium Binders
1.2.5 Calcium-Based Phosphate Binders
1.2.6 Other
1.3 Global End Stage Renal Disease Drug Market Size by Type
1.3.1 Global End Stage Renal Disease Drug Market Size Overview by Type (2024-2034)
1.3.2 Global End Stage Renal Disease Drug Historic Market Size Review by Type (2024-2024)
1.3.3 Global End Stage Renal Disease Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America End Stage Renal Disease Drug Sales Breakdown by Type (2024-2024)
1.4.2 Europe End Stage Renal Disease Drug Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific End Stage Renal Disease Drug Sales Breakdown by Type (2024-2024)
1.4.4 Latin America End Stage Renal Disease Drug Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa End Stage Renal Disease Drug Sales Breakdown by Type (2024-2024)
2 Global End Stage Renal Disease Drug Market Competition by Company
2.1 Global Top Players by End Stage Renal Disease Drug Sales (2024-2024)
2.2 Global Top Players by End Stage Renal Disease Drug Revenue (2024-2024)
2.3 Global Top Players by End Stage Renal Disease Drug Price (2024-2024)
2.4 Global Top Manufacturers End Stage Renal Disease Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 End Stage Renal Disease Drug Market Competitive Situation and Trends
2.5.1 End Stage Renal Disease Drug Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by End Stage Renal Disease Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in End Stage Renal Disease Drug as of 2022)
2.7 Date of Key Manufacturers Enter into End Stage Renal Disease Drug Market
2.8 Key Manufacturers End Stage Renal Disease Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 End Stage Renal Disease Drug Status and Outlook by Region
3.1 Global End Stage Renal Disease Drug Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global End Stage Renal Disease Drug Historic Market Size by Region
3.2.1 Global End Stage Renal Disease Drug Sales in Volume by Region (2024-2024)
3.2.2 Global End Stage Renal Disease Drug Sales in Value by Region (2024-2024)
3.2.3 Global End Stage Renal Disease Drug Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global End Stage Renal Disease Drug Forecasted Market Size by Region
3.3.1 Global End Stage Renal Disease Drug Sales in Volume by Region (2024-2034)
3.3.2 Global End Stage Renal Disease Drug Sales in Value by Region (2024-2034)
3.3.3 Global End Stage Renal Disease Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global End Stage Renal Disease Drug by Application
4.1 End Stage Renal Disease Drug Market Segment by Application
4.1.1 End Stage Renal Disease Induced Hyperparathyroidism
4.1.2 End Stage Renal Disease Induced Hyperphosphatemia
4.1.3 End Stage Renal Disease Induced Hyperkalaemia
4.2 Global End Stage Renal Disease Drug Market Size by Application
4.2.1 Global End Stage Renal Disease Drug Market Size Overview by Application (2024-2034)
4.2.2 Global End Stage Renal Disease Drug Historic Market Size Review by Application (2024-2024)
4.2.3 Global End Stage Renal Disease Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America End Stage Renal Disease Drug Sales Breakdown by Application (2024-2024)
4.3.2 Europe End Stage Renal Disease Drug Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific End Stage Renal Disease Drug Sales Breakdown by Application (2024-2024)
4.3.4 Latin America End Stage Renal Disease Drug Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa End Stage Renal Disease Drug Sales Breakdown by Application (2024-2024)
5 North America End Stage Renal Disease Drug by Country
5.1 North America End Stage Renal Disease Drug Historic Market Size by Country
5.1.1 North America End Stage Renal Disease Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America End Stage Renal Disease Drug Sales in Volume by Country (2024-2024)
5.1.3 North America End Stage Renal Disease Drug Sales in Value by Country (2024-2024)
5.2 North America End Stage Renal Disease Drug Forecasted Market Size by Country
5.2.1 North America End Stage Renal Disease Drug Sales in Volume by Country (2024-2034)
5.2.2 North America End Stage Renal Disease Drug Sales in Value by Country (2024-2034)
6 Europe End Stage Renal Disease Drug by Country
6.1 Europe End Stage Renal Disease Drug Historic Market Size by Country
6.1.1 Europe End Stage Renal Disease Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe End Stage Renal Disease Drug Sales in Volume by Country (2024-2024)
6.1.3 Europe End Stage Renal Disease Drug Sales in Value by Country (2024-2024)
6.2 Europe End Stage Renal Disease Drug Forecasted Market Size by Country
6.2.1 Europe End Stage Renal Disease Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe End Stage Renal Disease Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific End Stage Renal Disease Drug by Region
7.1 Asia-Pacific End Stage Renal Disease Drug Historic Market Size by Region
7.1.1 Asia-Pacific End Stage Renal Disease Drug Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific End Stage Renal Disease Drug Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific End Stage Renal Disease Drug Sales in Value by Region (2024-2024)
7.2 Asia-Pacific End Stage Renal Disease Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific End Stage Renal Disease Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific End Stage Renal Disease Drug Sales in Value by Region (2024-2034)
8 Latin America End Stage Renal Disease Drug by Country
8.1 Latin America End Stage Renal Disease Drug Historic Market Size by Country
8.1.1 Latin America End Stage Renal Disease Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America End Stage Renal Disease Drug Sales in Volume by Country (2024-2024)
8.1.3 Latin America End Stage Renal Disease Drug Sales in Value by Country (2024-2024)
8.2 Latin America End Stage Renal Disease Drug Forecasted Market Size by Country
8.2.1 Latin America End Stage Renal Disease Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America End Stage Renal Disease Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa End Stage Renal Disease Drug by Country
9.1 Middle East and Africa End Stage Renal Disease Drug Historic Market Size by Country
9.1.1 Middle East and Africa End Stage Renal Disease Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa End Stage Renal Disease Drug Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa End Stage Renal Disease Drug Sales in Value by Country (2024-2024)
9.2 Middle East and Africa End Stage Renal Disease Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa End Stage Renal Disease Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa End Stage Renal Disease Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer Inc
10.1.1 Pfizer Inc Company Information
10.1.2 Pfizer Inc Introduction and Business Overview
10.1.3 Pfizer Inc End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Pfizer Inc End Stage Renal Disease Drug Products Offered
10.1.5 Pfizer Inc Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2024-2024)
10.2.4 AstraZeneca End Stage Renal Disease Drug Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Bristol-Myers Squibb Company
10.3.1 Bristol-Myers Squibb Company Company Information
10.3.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.3.3 Bristol-Myers Squibb Company End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Bristol-Myers Squibb Company End Stage Renal Disease Drug Products Offered
10.3.5 Bristol-Myers Squibb Company Recent Development
10.4 Dr. Reddy's Laboratories Ltd
10.4.1 Dr. Reddy's Laboratories Ltd Company Information
10.4.2 Dr. Reddy's Laboratories Ltd Introduction and Business Overview
10.4.3 Dr. Reddy's Laboratories Ltd End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Dr. Reddy's Laboratories Ltd End Stage Renal Disease Drug Products Offered
10.4.5 Dr. Reddy's Laboratories Ltd Recent Development
10.5 Endo International plc
10.5.1 Endo International plc Company Information
10.5.2 Endo International plc Introduction and Business Overview
10.5.3 Endo International plc End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Endo International plc End Stage Renal Disease Drug Products Offered
10.5.5 Endo International plc Recent Development
10.6 Teva Pharmaceutical Industries Ltd
10.6.1 Teva Pharmaceutical Industries Ltd Company Information
10.6.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview
10.6.3 Teva Pharmaceutical Industries Ltd End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Teva Pharmaceutical Industries Ltd End Stage Renal Disease Drug Products Offered
10.6.5 Teva Pharmaceutical Industries Ltd Recent Development
10.7 Sun Pharmaceutical Industries Ltd
10.7.1 Sun Pharmaceutical Industries Ltd Company Information
10.7.2 Sun Pharmaceutical Industries Ltd Introduction and Business Overview
10.7.3 Sun Pharmaceutical Industries Ltd End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Sun Pharmaceutical Industries Ltd End Stage Renal Disease Drug Products Offered
10.7.5 Sun Pharmaceutical Industries Ltd Recent Development
10.8 Mylan NV
10.8.1 Mylan NV Company Information
10.8.2 Mylan NV Introduction and Business Overview
10.8.3 Mylan NV End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Mylan NV End Stage Renal Disease Drug Products Offered
10.8.5 Mylan NV Recent Development
10.9 Novartis AG
10.9.1 Novartis AG Company Information
10.9.2 Novartis AG Introduction and Business Overview
10.9.3 Novartis AG End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Novartis AG End Stage Renal Disease Drug Products Offered
10.9.5 Novartis AG Recent Development
10.10 Lupin
10.10.1 Lupin Company Information
10.10.2 Lupin Introduction and Business Overview
10.10.3 Lupin End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Lupin End Stage Renal Disease Drug Products Offered
10.10.5 Lupin Recent Development
10.11 Cipla Inc
10.11.1 Cipla Inc Company Information
10.11.2 Cipla Inc Introduction and Business Overview
10.11.3 Cipla Inc End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Cipla Inc End Stage Renal Disease Drug Products Offered
10.11.5 Cipla Inc Recent Development
10.12 Aurobindo Pharma
10.12.1 Aurobindo Pharma Company Information
10.12.2 Aurobindo Pharma Introduction and Business Overview
10.12.3 Aurobindo Pharma End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Aurobindo Pharma End Stage Renal Disease Drug Products Offered
10.12.5 Aurobindo Pharma Recent Development
10.13 Fresenius SE & Co. KGaA
10.13.1 Fresenius SE & Co. KGaA Company Information
10.13.2 Fresenius SE & Co. KGaA Introduction and Business Overview
10.13.3 Fresenius SE & Co. KGaA End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Fresenius SE & Co. KGaA End Stage Renal Disease Drug Products Offered
10.13.5 Fresenius SE & Co. KGaA Recent Development
10.14 Sanofi
10.14.1 Sanofi Company Information
10.14.2 Sanofi Introduction and Business Overview
10.14.3 Sanofi End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Sanofi End Stage Renal Disease Drug Products Offered
10.14.5 Sanofi Recent Development
10.15 Takeda Pharmaceutical Company Limited
10.15.1 Takeda Pharmaceutical Company Limited Company Information
10.15.2 Takeda Pharmaceutical Company Limited Introduction and Business Overview
10.15.3 Takeda Pharmaceutical Company Limited End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Takeda Pharmaceutical Company Limited End Stage Renal Disease Drug Products Offered
10.15.5 Takeda Pharmaceutical Company Limited Recent Development
10.16 F. Hoffmann-La Roche Ltd
10.16.1 F. Hoffmann-La Roche Ltd Company Information
10.16.2 F. Hoffmann-La Roche Ltd Introduction and Business Overview
10.16.3 F. Hoffmann-La Roche Ltd End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2024-2024)
10.16.4 F. Hoffmann-La Roche Ltd End Stage Renal Disease Drug Products Offered
10.16.5 F. Hoffmann-La Roche Ltd Recent Development
10.17 Kissei Pharmaceutical Co., Ltd
10.17.1 Kissei Pharmaceutical Co., Ltd Company Information
10.17.2 Kissei Pharmaceutical Co., Ltd Introduction and Business Overview
10.17.3 Kissei Pharmaceutical Co., Ltd End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2024-2024)
10.17.4 Kissei Pharmaceutical Co., Ltd End Stage Renal Disease Drug Products Offered
10.17.5 Kissei Pharmaceutical Co., Ltd Recent Development
10.18 Abbott
10.18.1 Abbott Company Information
10.18.2 Abbott Introduction and Business Overview
10.18.3 Abbott End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2024-2024)
10.18.4 Abbott End Stage Renal Disease Drug Products Offered
10.18.5 Abbott Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 End Stage Renal Disease Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 End Stage Renal Disease Drug Industrial Chain Analysis
11.4 End Stage Renal Disease Drug Market Dynamics
11.4.1 End Stage Renal Disease Drug Industry Trends
11.4.2 End Stage Renal Disease Drug Market Drivers
11.4.3 End Stage Renal Disease Drug Market Challenges
11.4.4 End Stage Renal Disease Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 End Stage Renal Disease Drug Distributors
12.3 End Stage Renal Disease Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Calcimimetics
Table 2. Major Company of Vitamin D
Table 3. Major Company of Sterols
Table 4. Major Company of Potassium Binders
Table 5. Major Company of Calcium-Based Phosphate Binders
Table 6. Major Company of Other
Table 7. Global End Stage Renal Disease Drug Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 8. Global End Stage Renal Disease Drug Sales by Type (2024-2024) & (K Units)
Table 9. Global End Stage Renal Disease Drug Sales Market Share in Volume by Type (2024-2024)
Table 10. Global End Stage Renal Disease Drug Sales by Type (2024-2024) & (US& Million)
Table 11. Global End Stage Renal Disease Drug Market Share in Value by Type (2024-2024)
Table 12. Global End Stage Renal Disease Drug Price by Type (2024-2024) & (US$/Unit)
Table 13. Global End Stage Renal Disease Drug Sales by Type (2024-2034) & (K Units)
Table 14. Global End Stage Renal Disease Drug Sales Market Share in Volume by Type (2024-2034)
Table 15. Global End Stage Renal Disease Drug Sales by Type (2024-2034) & (US$ Million)
Table 16. Global End Stage Renal Disease Drug Sales Market Share in Value by Type (2024-2034)
Table 17. Global End Stage Renal Disease Drug Price by Type (2024-2034) & (US$/Unit)
Table 18. North America End Stage Renal Disease Drug Sales by Type (2024-2024) & (K Units)
Table 19. North America End Stage Renal Disease Drug Sales by Type (2024-2024) & (US$ Million)
Table 20. Europe End Stage Renal Disease Drug Sales (K Units) by Type (2024-2024)
Table 21. Europe End Stage Renal Disease Drug Sales by Type (2024-2024) & (US$ Million)
Table 22. Asia-Pacific End Stage Renal Disease Drug Sales (K Units) by Type (2024-2024)
Table 23. Asia-Pacific End Stage Renal Disease Drug Sales by Type (2024-2024) & (US$ Million)
Table 24. Latin America End Stage Renal Disease Drug Sales (K Units) by Type (2024-2024)
Table 25. Latin America End Stage Renal Disease Drug Sales by Type (2024-2024) & (US$ Million)
Table 26. Middle East and Africa End Stage Renal Disease Drug Sales (K Units) by Type (2024-2024)
Table 27. Middle East and Africa End Stage Renal Disease Drug Sales by Type (2024-2024) & (US$ Million)
Table 28. Global End Stage Renal Disease Drug Sales by Company (2024-2024) & (K Units)
Table 29. Global End Stage Renal Disease Drug Sales Share by Company (2024-2024)
Table 30. Global End Stage Renal Disease Drug Revenue by Company (2024-2024) & (US$ Million)
Table 31. Global End Stage Renal Disease Drug Revenue Share by Company (2024-2024)
Table 32. Global Market End Stage Renal Disease Drug Price by Company (2024-2024) & (US$/Unit)
Table 33. Global End Stage Renal Disease Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global End Stage Renal Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in End Stage Renal Disease Drug as of 2022)
Table 36. Date of Key Manufacturers Enter into End Stage Renal Disease Drug Market
Table 37. Key Manufacturers End Stage Renal Disease Drug Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global End Stage Renal Disease Drug Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 40. Global End Stage Renal Disease Drug Sales by Region (2024-2024) & (K Units)
Table 41. Global End Stage Renal Disease Drug Sales Market Share in Volume by Region (2024-2024)
Table 42. Global End Stage Renal Disease Drug Sales by Region (2024-2024) & (US$ Million)
Table 43. Global End Stage Renal Disease Drug Sales Market Share in Value by Region (2024-2024)
Table 44. Global End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 45. Global End Stage Renal Disease Drug Sales by Region (2024-2034) & (K Units)
Table 46. Global End Stage Renal Disease Drug Sales Market Share in Volume by Region (2024-2034)
Table 47. Global End Stage Renal Disease Drug Sales by Region (2024-2034) & (US$ Million)
Table 48. Global End Stage Renal Disease Drug Sales Market Share in Value by Region (2024-2034)
Table 49. Global End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 50. Global End Stage Renal Disease Drug Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 51. Global End Stage Renal Disease Drug Sales by Application (2024-2024) & (K Units)
Table 52. Global End Stage Renal Disease Drug Sales Market Share in Volume by Application (2024-2024)
Table 53. Global End Stage Renal Disease Drug Sales by Application (2024-2024) & (US$ Million)
Table 54. Global End Stage Renal Disease Drug Sales Market Share in Value by Application (2024-2024)
Table 55. Global End Stage Renal Disease Drug Price by Application (2024-2024) & (US$/Unit)
Table 56. Global End Stage Renal Disease Drug Sales by Application (2024-2034) & (K Units)
Table 57. Global End Stage Renal Disease Drug Sales Market Share in Volume by Application (2024-2034)
Table 58. Global End Stage Renal Disease Drug Sales by Application (2024-2034) & (US$ Million)
Table 59. Global End Stage Renal Disease Drug Sales Market Share in Value by Application (2024-2034)
Table 60. Global End Stage Renal Disease Drug Price by Application (2024-2034) & (US$/Unit)
Table 61. North America End Stage Renal Disease Drug Sales by Application (2024-2024) (K Units)
Table 62. North America End Stage Renal Disease Drug Sales by Application (2024-2024) & (US$ Million)
Table 63. Europe End Stage Renal Disease Drug Sales by Application (2024-2024) (K Units)
Table 64. Europe End Stage Renal Disease Drug Sales by Application (2024-2024) & (US$ Million)
Table 65. Asia-Pacific End Stage Renal Disease Drug Sales by Application (2024-2024) (K Units)
Table 66. Asia-Pacific End Stage Renal Disease Drug Sales by Application (2024-2024) & (US$ Million)
Table 67. Latin America End Stage Renal Disease Drug Sales by Application (2024-2024) (K Units)
Table 68. Latin America End Stage Renal Disease Drug Sales by Application (2024-2024) & (US$ Million)
Table 69. Middle East and Africa End Stage Renal Disease Drug Sales by Application (2024-2024) (K Units)
Table 70. Middle East and Africa End Stage Renal Disease Drug Sales by Application (2024-2024) & (US$ Million)
Table 71. North America End Stage Renal Disease Drug Sales by Country (2024-2024) & (K Units)
Table 72. North America End Stage Renal Disease Drug Sales Market Share in Volume by Country (2024-2024)
Table 73. North America End Stage Renal Disease Drug Sales by Country (2024-2024) & (US$ Million)
Table 74. North America End Stage Renal Disease Drug Sales Market Share in Value by Country (2024-2024)
Table 75. North America End Stage Renal Disease Drug Sales by Country (2024-2034) & (K Units)
Table 76. North America End Stage Renal Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 77. North America End Stage Renal Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 78. North America End Stage Renal Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 79. Europe End Stage Renal Disease Drug Sales by Country (2024-2024) & (K Units)
Table 80. Europe End Stage Renal Disease Drug Sales Market Share in Volume by Country (2024-2024)
Table 81. Europe End Stage Renal Disease Drug Sales by Country (2024-2024) & (US$ Million)
Table 82. Europe End Stage Renal Disease Drug Sales Market Share in Value by Country (2024-2024)
Table 83. Europe End Stage Renal Disease Drug Sales by Country (2024-2034) & (K Units)
Table 84. Europe End Stage Renal Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe End Stage Renal Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe End Stage Renal Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific End Stage Renal Disease Drug Sales by Region (2024-2024) & (K Units)
Table 88. Asia-Pacific End Stage Renal Disease Drug Sales Market Share in Volume by Region (2024-2024)
Table 89. Asia-Pacific End Stage Renal Disease Drug Sales by Region (2024-2024) & (US$ Million)
Table 90. Asia-Pacific End Stage Renal Disease Drug Sales Market Share in Value by Region (2024-2024)
Table 91. Asia-Pacific End Stage Renal Disease Drug Sales by Region (2024-2034) & (K Units)
Table 92. Asia-Pacific End Stage Renal Disease Drug Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific End Stage Renal Disease Drug Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific End Stage Renal Disease Drug Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America End Stage Renal Disease Drug Sales by Country (2024-2024) & (K Units)
Table 96. Latin America End Stage Renal Disease Drug Sales Market Share in Volume by Country (2024-2024)
Table 97. Latin America End Stage Renal Disease Drug Sales by Country (2024-2024) & (US$ Million)
Table 98. Latin America End Stage Renal Disease Drug Sales Market Share in Value by Country (2024-2024)
Table 99. Latin America End Stage Renal Disease Drug Sales by Country (2024-2034) & (K Units)
Table 100. Latin America End Stage Renal Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America End Stage Renal Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America End Stage Renal Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa End Stage Renal Disease Drug Sales by Country (2024-2024) & (K Units)
Table 104. Middle East and Africa End Stage Renal Disease Drug Sales Market Share in Volume by Country (2024-2024)
Table 105. Middle East and Africa End Stage Renal Disease Drug Sales by Country (2024-2024) & (US$ Million)
Table 106. Middle East and Africa End Stage Renal Disease Drug Sales Market Share in Value by Country (2024-2024)
Table 107. Middle East and Africa End Stage Renal Disease Drug Sales by Country (2024-2034) & (K Units)
Table 108. Middle East and Africa End Stage Renal Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa End Stage Renal Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa End Stage Renal Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 111. Pfizer Inc Company Information
Table 112. Pfizer Inc Introduction and Business Overview
Table 113. Pfizer Inc End Stage Renal Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 114. Pfizer Inc End Stage Renal Disease Drug Product
Table 115. Pfizer Inc Recent Development
Table 116. AstraZeneca Company Information
Table 117. AstraZeneca Introduction and Business Overview
Table 118. AstraZeneca End Stage Renal Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 119. AstraZeneca End Stage Renal Disease Drug Product
Table 120. AstraZeneca Recent Development
Table 121. Bristol-Myers Squibb Company Company Information
Table 122. Bristol-Myers Squibb Company Introduction and Business Overview
Table 123. Bristol-Myers Squibb Company End Stage Renal Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 124. Bristol-Myers Squibb Company End Stage Renal Disease Drug Product
Table 125. Bristol-Myers Squibb Company Recent Development
Table 126. Dr. Reddy's Laboratories Ltd Company Information
Table 127. Dr. Reddy's Laboratories Ltd Introduction and Business Overview
Table 128. Dr. Reddy's Laboratories Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 129. Dr. Reddy's Laboratories Ltd End Stage Renal Disease Drug Product
Table 130. Dr. Reddy's Laboratories Ltd Recent Development
Table 131. Endo International plc Company Information
Table 132. Endo International plc Introduction and Business Overview
Table 133. Endo International plc End Stage Renal Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 134. Endo International plc End Stage Renal Disease Drug Product
Table 135. Endo International plc Recent Development
Table 136. Teva Pharmaceutical Industries Ltd Company Information
Table 137. Teva Pharmaceutical Industries Ltd Introduction and Business Overview
Table 138. Teva Pharmaceutical Industries Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 139. Teva Pharmaceutical Industries Ltd End Stage Renal Disease Drug Product
Table 140. Teva Pharmaceutical Industries Ltd Recent Development
Table 141. Sun Pharmaceutical Industries Ltd Company Information
Table 142. Sun Pharmaceutical Industries Ltd Introduction and Business Overview
Table 143. Sun Pharmaceutical Industries Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 144. Sun Pharmaceutical Industries Ltd End Stage Renal Disease Drug Product
Table 145. Sun Pharmaceutical Industries Ltd Recent Development
Table 146. Mylan NV Company Information
Table 147. Mylan NV Introduction and Business Overview
Table 148. Mylan NV End Stage Renal Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 149. Mylan NV End Stage Renal Disease Drug Product
Table 150. Mylan NV Recent Development
Table 151. Novartis AG Company Information
Table 152. Novartis AG Introduction and Business Overview
Table 153. Novartis AG End Stage Renal Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 154. Novartis AG End Stage Renal Disease Drug Product
Table 155. Novartis AG Recent Development
Table 156. Lupin Company Information
Table 157. Lupin Introduction and Business Overview
Table 158. Lupin End Stage Renal Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 159. Lupin End Stage Renal Disease Drug Product
Table 160. Lupin Recent Development
Table 161. Cipla Inc Company Information
Table 162. Cipla Inc Introduction and Business Overview
Table 163. Cipla Inc End Stage Renal Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 164. Cipla Inc End Stage Renal Disease Drug Product
Table 165. Cipla Inc Recent Development
Table 166. Aurobindo Pharma Company Information
Table 167. Aurobindo Pharma Introduction and Business Overview
Table 168. Aurobindo Pharma End Stage Renal Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 169. Aurobindo Pharma End Stage Renal Disease Drug Product
Table 170. Aurobindo Pharma Recent Development
Table 171. Fresenius SE & Co. KGaA Company Information
Table 172. Fresenius SE & Co. KGaA Introduction and Business Overview
Table 173. Fresenius SE & Co. KGaA End Stage Renal Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 174. Fresenius SE & Co. KGaA End Stage Renal Disease Drug Product
Table 175. Fresenius SE & Co. KGaA Recent Development
Table 176. Sanofi Company Information
Table 177. Sanofi Introduction and Business Overview
Table 178. Sanofi End Stage Renal Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 179. Sanofi End Stage Renal Disease Drug Product
Table 180. Sanofi Recent Development
Table 181. Takeda Pharmaceutical Company Limited Company Information
Table 182. Takeda Pharmaceutical Company Limited Introduction and Business Overview
Table 183. Takeda Pharmaceutical Company Limited End Stage Renal Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 184. Takeda Pharmaceutical Company Limited End Stage Renal Disease Drug Product
Table 185. Takeda Pharmaceutical Company Limited Recent Development
Table 186. F. Hoffmann-La Roche Ltd Company Information
Table 187. F. Hoffmann-La Roche Ltd Introduction and Business Overview
Table 188. F. Hoffmann-La Roche Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 189. F. Hoffmann-La Roche Ltd End Stage Renal Disease Drug Product
Table 190. F. Hoffmann-La Roche Ltd Recent Development
Table 191. Kissei Pharmaceutical Co., Ltd Company Information
Table 192. Kissei Pharmaceutical Co., Ltd Introduction and Business Overview
Table 193. Kissei Pharmaceutical Co., Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 194. Kissei Pharmaceutical Co., Ltd End Stage Renal Disease Drug Product
Table 195. Kissei Pharmaceutical Co., Ltd Recent Development
Table 196. Abbott Company Information
Table 197. Abbott Introduction and Business Overview
Table 198. Abbott End Stage Renal Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 199. Abbott End Stage Renal Disease Drug Product
Table 200. Abbott Recent Development
Table 201. Key Raw Materials Lists
Table 202. Raw Materials Key Suppliers Lists
Table 203. End Stage Renal Disease Drug Market Trends
Table 204. End Stage Renal Disease Drug Market Drivers
Table 205. End Stage Renal Disease Drug Market Challenges
Table 206. End Stage Renal Disease Drug Market Restraints
Table 207. End Stage Renal Disease Drug Distributors List
Table 208. End Stage Renal Disease Drug Downstream Customers
Table 209. Research Programs/Design for This Report
Table 210. Key Data Information from Secondary Sources
Table 211. Key Data Information from Primary Sources
List of Figures
Figure 1. End Stage Renal Disease Drug Product Picture
Figure 2. Global End Stage Renal Disease Drug Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global End Stage Renal Disease Drug Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global End Stage Renal Disease Drug Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Calcimimetics
Figure 6. Global Calcimimetics Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Vitamin D
Figure 8. Global Vitamin D Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Sterols
Figure 10. Global Sterols Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Potassium Binders
Figure 12. Global Potassium Binders Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of Calcium-Based Phosphate Binders
Figure 14. Global Calcium-Based Phosphate Binders Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Product Picture of Other
Figure 16. Global Other Sales YoY Growth (2024-2034) & (K Units)
Figure 17. Global End Stage Renal Disease Drug Sales by Type (2024-2034) & (US$ Million)
Figure 18. Global End Stage Renal Disease Drug Sales Market Share by Type in 2022 & 2034
Figure 19. North America End Stage Renal Disease Drug Sales Market Share in Volume by Type in 2022
Figure 20. North America End Stage Renal Disease Drug Sales Market Share in Value by Type in 2022
Figure 21. Europe End Stage Renal Disease Drug Sales Market Share in Volume by Type in 2022
Figure 22. Europe End Stage Renal Disease Drug Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific End Stage Renal Disease Drug Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific End Stage Renal Disease Drug Sales Market Share in Value by Type in 2022
Figure 25. Latin America End Stage Renal Disease Drug Sales Market Share in Volume by Type in 2022
Figure 26. Latin America End Stage Renal Disease Drug Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa End Stage Renal Disease Drug Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa End Stage Renal Disease Drug Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by End Stage Renal Disease Drug Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by End Stage Renal Disease Drug Revenue in 2022
Figure 31. End Stage Renal Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 32. Product Picture of End Stage Renal Disease Induced Hyperparathyroidism
Figure 33. Global End Stage Renal Disease Induced Hyperparathyroidism Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of End Stage Renal Disease Induced Hyperphosphatemia
Figure 35. Global End Stage Renal Disease Induced Hyperphosphatemia Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Product Picture of End Stage Renal Disease Induced Hyperkalaemia
Figure 37. Global End Stage Renal Disease Induced Hyperkalaemia Sales YoY Growth (2024-2034) & (K Units)
Figure 38. Global End Stage Renal Disease Drug Sales by Application (2024-2034) & (US$ Million)
Figure 39. Global End Stage Renal Disease Drug Sales Market Share by Application in 2022 & 2034
Figure 40. North America End Stage Renal Disease Drug Sales Market Share in Volume by Application in 2022
Figure 41. North America End Stage Renal Disease Drug Sales Market Share in Value by Application in 2022
Figure 42. Europe End Stage Renal Disease Drug Sales Market Share in Volume by Application in 2022
Figure 43. Europe End Stage Renal Disease Drug Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific End Stage Renal Disease Drug Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific End Stage Renal Disease Drug Sales Market Share in Value by Application in 2022
Figure 46. Latin America End Stage Renal Disease Drug Sales Market Share in Volume by Application in 2022
Figure 47. Latin America End Stage Renal Disease Drug Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa End Stage Renal Disease Drug Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. End Stage Renal Disease Drug Manufacturing Cost Structure
Figure 51. End Stage Renal Disease Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries